Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Novo Nordisk A/S (NVO) has a Wall Street consensus price target of $47.00, based on estimates from 39 covering analysts. With the stock currently trading at $37.45, this represents a potential upside of +25.5%. The company has a market capitalization of $126.28B.
Analyst price targets range from a low of $42.00 to a high of $54.00, representing a 26% spread in expectations. The median target of $45.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 24 analysts rating the stock as a Buy or Strong Buy,12 rating it Hold, and 3 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, NVO trades at a trailing P/E of 10.3x and forward P/E of 1.8x. The forward PEG ratio of 0.09 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -3.8% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $274.76, with bear and bull scenarios of $202.25 and $414.41 respectively. Model confidence stands at 52/100, reflecting moderate uncertainty in projections.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how NVO stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for NVO is $47, representing 25.5% upside from the current price of $37.45. With 39 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
NVO has a consensus rating of "Buy" based on 39 Wall Street analysts. The rating breakdown is predominantly bullish, with 24 Buy/Strong Buy ratings. The consensus 12-month price target of $47 implies 25.5% upside from current levels.
With a forward P/E of 1.7579x, NVO trades at a relatively low valuation. The consensus target of $47 implies 25.5% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $54 for NVO, while the most conservative target is $42. The consensus of $47 represents the median expectation. Our quantitative valuation model projects a bull case target of $414 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
NVO is heavily covered by Wall Street, with 39 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 23 have Buy ratings, 12 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month NVO stock forecast based on 39 Wall Street analysts shows a consensus price target of $47, with estimates ranging from $42 (bear case) to $54 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $275, with bear/bull scenarios of $202/$414.
Our quantitative valuation model calculates NVO's fair value at $275 (base case), with a bear case of $202 and bull case of $414. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 52/100.
NVO trades at a forward P/E ratio of 1.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 10.3x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on NVO, with a "Buy" consensus rating and $47 price target (25.5% upside). 24 of 39 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
NVO analyst price targets range from $42 to $54, a 26% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $47 consensus represents the middle ground. Our model's $202-$414 range provides an independent fundamental perspective.